Published in Microbiol Mol Biol Rev on June 01, 2007
Comprehensive characterization of extracellular herpes simplex virus type 1 virions. J Virol (2008) 2.30
Viral control of mitochondrial apoptosis. PLoS Pathog (2008) 2.21
Cellular proteins in influenza virus particles. PLoS Pathog (2008) 1.96
In-depth study of Mollivirus sibericum, a new 30,000-y-old giant virus infecting Acanthamoeba. Proc Natl Acad Sci U S A (2015) 1.72
Plus- and minus-end directed microtubule motors bind simultaneously to herpes simplex virus capsids using different inner tegument structures. PLoS Pathog (2010) 1.59
Fatty acid synthase is up-regulated during hepatitis C virus infection and regulates hepatitis C virus entry and production. Hepatology (2008) 1.52
Viral manipulation of DNA repair and cell cycle checkpoints. DNA Repair (Amst) (2009) 1.37
Temporal dynamics of cytomegalovirus chromatin assembly in productively infected human cells. J Virol (2008) 1.35
Proteomic characterization of pseudorabies virus extracellular virions. J Virol (2011) 1.30
During lytic infections, herpes simplex virus type 1 DNA is in complexes with the properties of unstable nucleosomes. J Virol (2009) 1.08
Chromatin organization and virus gene expression. J Cell Physiol (2008) 1.08
Structural principles within the human-virus protein-protein interaction network. Proc Natl Acad Sci U S A (2011) 1.05
Mycoplasma pneumoniae infection induces reactive oxygen species and DNA damage in A549 human lung carcinoma cells. Infect Immun (2008) 1.03
Identification of essential filovirion-associated host factors by serial proteomic analysis and RNAi screen. Mol Cell Proteomics (2010) 0.98
Pirates of the Caudovirales. Virology (2012) 0.98
Tegument protein control of latent herpesvirus establishment and animation. Herpesviridae (2011) 0.98
Isolation and preliminary characterization of herpes simplex virus 1 primary enveloped virions from the perinuclear space. J Virol (2009) 0.96
Global approaches to study protein-protein interactions among viruses and hosts. Future Microbiol (2010) 0.92
Deciphering novel host-herpesvirus interactions by virion proteomics. Front Microbiol (2012) 0.92
Quantitative proteomics analysis reveals BAG3 as a potential target to suppress severe acute respiratory syndrome coronavirus replication. J Virol (2010) 0.91
Proteomic characterization of influenza H5N1 virus-like particles and their protective immunogenicity. J Proteome Res (2011) 0.91
Roseophage RDJL Phi1, infecting the aerobic anoxygenic phototrophic bacterium Roseobacter denitrificans OCh114. Appl Environ Microbiol (2009) 0.91
Proteomic analysis reveals selective impediment of neuronal remodeling upon Borna disease virus infection. J Virol (2008) 0.88
The proteome of human cytomegalovirus virions and dense bodies is conserved across different strains. Med Microbiol Immunol (2015) 0.87
Cyclin-dependent kinase 1/cyclin B1 phosphorylates varicella-zoster virus IE62 and is incorporated into virions. J Virol (2008) 0.84
Proteomic analysis of purified coronavirus infectious bronchitis virus particles. Proteome Sci (2010) 0.82
Profiling of cellular proteins in porcine reproductive and respiratory syndrome virus virions by proteomics analysis. Virol J (2010) 0.81
Global landscape of structural proteins of infectious spleen and kidney necrosis virus. J Virol (2011) 0.80
Proteomics of HCV virions reveals an essential role for the nucleoporin Nup98 in virus morphogenesis. Proc Natl Acad Sci U S A (2016) 0.79
Altered protein networks and cellular pathways in severe west nile disease in mice. PLoS One (2013) 0.79
Protein interactions during the flavivirus and hepacivirus life cycle. Mol Cell Proteomics (2017) 0.79
White spot syndrome virus proteins and differentially expressed host proteins identified in shrimp epithelium by shotgun proteomics and cleavable isotope-coded affinity tag. J Virol (2007) 0.79
Identification of cellular proteome using two-dimensional difference gel electrophoresis in ST cells infected with transmissible gastroenteritis coronavirus. Proteome Sci (2013) 0.78
Retracted Hijacking of host calreticulin is required for the white spot syndrome virus replication cycle. J Virol (2014) 0.78
Quantitative iTRAQ LC-MS/MS proteomics reveals the proteome profiles of DF-1 cells after infection with subgroup J Avian leukosis virus. Biomed Res Int (2015) 0.77
Chromatinization of the KSHV Genome During the KSHV Life Cycle. Cancers (Basel) (2015) 0.77
Identification of different respiratory viruses, after a cell culture step, by matrix assisted laser desorption/ionization time of flight mass spectrometry (MALDI-TOF MS). Sci Rep (2016) 0.76
Development of an Efficient Virus Induced Gene Silencing Strategy in the Non-Model Wild Ginger-Zingiber zerumbet and Investigation of Associated Proteome Changes. PLoS One (2015) 0.76
Proteomics profiling of chikungunya-infected Aedes albopictus C6/36 cells reveal important mosquito cell factors in virus replication. PLoS Negl Trop Dis (2015) 0.76
Role of genomic and proteomic tools in the study of host-virus interactions and virus evolution. Indian J Virol (2013) 0.75
P64, a novel major virion DNA-binding protein potentially involved in condensing the Spodoptera frugiperda Ascovirus 1a genome. J Virol (2009) 0.75
Label-free quantitative mass spectrometry for analysis of protein antigens in a meningococcal group B outer membrane vesicle vaccine. Hum Vaccin Immunother (2015) 0.75
Proteomic analysis of purified Newcastle disease virus particles. Proteome Sci (2012) 0.75
The chromatin remodeling factor SMARCB1 forms a complex with human cytomegalovirus proteins UL114 and UL44. PLoS One (2012) 0.75
Canonical and variant forms of histone H3 are deposited onto the human cytomegalovirus genome during lytic and latent infections. J Virol (2016) 0.75
hCLE/C14orf166, a cellular protein required for viral replication, is incorporated into influenza virus particles. Sci Rep (2016) 0.75
Nucleotide sequence of bacteriophage phi X174 DNA. Nature (1977) 95.69
A novel genetic system to detect protein-protein interactions. Nature (1989) 43.83
Stable isotope labeling by amino acids in cell culture, SILAC, as a simple and accurate approach to expression proteomics. Mol Cell Proteomics (2002) 30.58
DNA sequence and expression of the B95-8 Epstein-Barr virus genome. Nature (1984) 27.05
A generic protein purification method for protein complex characterization and proteome exploration. Nat Biotechnol (1999) 25.13
Global landscape of protein complexes in the yeast Saccharomyces cerevisiae. Nature (2006) 24.29
Quantitative analysis of complex protein mixtures using isotope-coded affinity tags. Nat Biotechnol (1999) 21.92
Proteome survey reveals modularity of the yeast cell machinery. Nature (2006) 20.77
Characterization of a novel coronavirus associated with severe acute respiratory syndrome. Science (2003) 18.34
Correlation between protein and mRNA abundance in yeast. Mol Cell Biol (1999) 16.95
The Genome sequence of the SARS-associated coronavirus. Science (2003) 16.68
Analysis of the protein-coding content of the sequence of human cytomegalovirus strain AD169. Curr Top Microbiol Immunol (1990) 16.31
The 1.2-megabase genome sequence of Mimivirus. Science (2004) 8.37
The operator-binding domain of lambda repressor: structure and DNA recognition. Nature (1982) 6.03
Structure of the cro repressor from bacteriophage lambda and its interaction with DNA. Nature (1981) 5.24
Difference gel electrophoresis: a single gel method for detecting changes in protein extracts. Electrophoresis (1997) 5.06
Herpesviral protein networks and their interaction with the human proteome. Science (2005) 4.74
Crystal structure of the RNA-dependent RNA polymerase from hepatitis C virus reveals a fully encircled active site. Nat Struct Biol (1999) 4.37
Identification of proteins in human cytomegalovirus (HCMV) particles: the HCMV proteome. J Virol (2004) 4.30
Crystal structure of the hepatitis C virus NS3 protease domain complexed with a synthetic NS4A cofactor peptide. Cell (1996) 4.12
Integrated genomic and proteomic analyses of gene expression in Mammalian cells. Mol Cell Proteomics (2004) 4.09
Structure of the zinc-binding domain of an essential component of the hepatitis C virus replicase. Nature (2005) 3.83
Structure of the hepatitis C virus RNA helicase domain. Nat Struct Biol (1997) 3.80
Proteomic and biochemical analysis of purified human immunodeficiency virus type 1 produced from infected monocyte-derived macrophages. J Virol (2006) 3.59
Quantitative membrane proteomics reveals new cellular targets of viral immune modulators. PLoS Pathog (2006) 3.57
A protein linkage map of Escherichia coli bacteriophage T7. Nat Genet (1996) 3.45
Mass spectrometric-based approaches in quantitative proteomics. Methods (2003) 3.38
Microvesicles are a source of contaminating cellular proteins found in purified HIV-1 preparations. Virology (1997) 3.24
In a nutshell: structure and assembly of the vaccinia virion. Adv Virus Res (2006) 3.17
Isolation of three proteins that bind to mammalian RNA polymerase II. J Biol Chem (1985) 3.11
Proteins of purified Epstein-Barr virus. Proc Natl Acad Sci U S A (2004) 3.11
Proteins associated with purified human cytomegalovirus particles. J Virol (1996) 3.01
Fluorescent proteins as proteomic probes. Mol Cell Proteomics (2005) 2.98
The crystal structure of hepatitis C virus NS3 proteinase reveals a trypsin-like fold and a structural zinc binding site. Cell (1996) 2.81
Genome-wide analysis of vaccinia virus protein-protein interactions. Proc Natl Acad Sci U S A (2000) 2.81
Bridging structural biology and genomics: assessing protein interaction data with known complexes. Trends Genet (2002) 2.65
Structure of the catalytic domain of the hepatitis C virus NS2-3 protease. Nature (2006) 2.58
Structural basis of severe acute respiratory syndrome coronavirus ADP-ribose-1''-phosphate dephosphorylation by a conserved domain of nsP3. Structure (2005) 2.55
Vaccinia virus proteome: identification of proteins in vaccinia virus intracellular mature virion particles. J Virol (2006) 2.38
Virion proteins of Kaposi's sarcoma-associated herpesvirus. J Virol (2005) 2.38
Determination of interactions between tegument proteins of herpes simplex virus type 1. J Virol (2005) 2.31
Cell membrane vesicles are a major contaminant of gradient-enriched human immunodeficiency virus type-1 preparations. Virology (1997) 2.30
Severe acute respiratory syndrome coronavirus papain-like protease: structure of a viral deubiquitinating enzyme. Proc Natl Acad Sci U S A (2006) 2.28
Proteomics of herpes simplex virus replication compartments: association of cellular DNA replication, repair, recombination, and chromatin remodeling proteins with ICP8. J Virol (2004) 2.27
Sequential Peptide Affinity (SPA) system for the identification of mammalian and bacterial protein complexes. J Proteome Res (2004) 2.16
Poxvirus multiprotein entry-fusion complex. Proc Natl Acad Sci U S A (2005) 2.09
Identification of the major membrane and core proteins of vaccinia virus by two-dimensional electrophoresis. J Virol (1996) 2.08
Tracking and elucidating alphavirus-host protein interactions. J Biol Chem (2006) 2.01
Mimivirus and the emerging concept of "giant" virus. Virus Res (2006) 1.98
Structure of the p53 binding domain of HAUSP/USP7 bound to Epstein-Barr nuclear antigen 1 implications for EBV-mediated immortalization. Mol Cell (2005) 1.92
Crystal structure of the DNA-binding domain of the Epstein-Barr virus origin-binding protein EBNA 1. Cell (1995) 1.87
Protein profiling with Epstein-Barr nuclear antigen-1 reveals an interaction with the herpesvirus-associated ubiquitin-specific protease HAUSP/USP7. J Biol Chem (2003) 1.78
Mimivirus giant particles incorporate a large fraction of anonymous and unique gene products. J Virol (2006) 1.76
Identification of proteins associated with murine gammaherpesvirus 68 virions. J Virol (2003) 1.75
Host and viral proteins in the virion of Kaposi's sarcoma-associated herpesvirus. J Virol (2005) 1.74
Identification of proteins associated with murine cytomegalovirus virions. J Virol (2004) 1.72
A genomic approach of the hepatitis C virus generates a protein interaction map. Gene (2000) 1.72
N-terminal amino acid sequences of vaccinia virus structural proteins. Virology (1994) 1.71
Pox proteomics: mass spectrometry analysis and identification of Vaccinia virion proteins. Virol J (2006) 1.69
Genomic and proteomic analysis of thirty-nine structural proteins of shrimp white spot syndrome virus. J Virol (2004) 1.65
Integrated molecular signature of disease: analysis of influenza virus-infected macaques through functional genomics and proteomics. J Virol (2006) 1.63
The severe acute respiratory syndrome-coronavirus replicative protein nsp9 is a single-stranded RNA-binding subunit unique in the RNA virus world. Proc Natl Acad Sci U S A (2004) 1.61
Plunder and stowaways: incorporation of cellular proteins by enveloped viruses. J Virol (2005) 1.56
The nsp9 replicase protein of SARS-coronavirus, structure and functional insights. Structure (2004) 1.55
Viral modulators of cullin RING ubiquitin ligases: culling the host defense. Sci STKE (2006) 1.54
The Epstein-Barr virus BFRF1 and BFLF2 proteins interact and coexpression alters their cellular localization. Virology (2004) 1.54
The structural proteome of Pseudomonas aeruginosa bacteriophage phiKMV. Microbiology (2006) 1.50
Proteomic analysis of shrimp white spot syndrome viral proteins and characterization of a novel envelope protein VP466. Mol Cell Proteomics (2002) 1.49
Functional genomics analysis of Singapore grouper iridovirus: complete sequence determination and proteomic analysis. J Virol (2004) 1.44
Crystal structure of the measles virus phosphoprotein domain responsible for the induced folding of the C-terminal domain of the nucleoprotein. J Biol Chem (2003) 1.43
Identification of the nucleocapsid, tegument, and envelope proteins of the shrimp white spot syndrome virus virion. J Virol (2006) 1.42
Investigative proteomics: identification of an unknown plant virus from infected plants using mass spectrometry. J Am Soc Mass Spectrom (2003) 1.38
Detection technologies in proteome analysis. J Chromatogr B Analyt Technol Biomed Life Sci (2002) 1.34
Proteome analysis of liver cells expressing a full-length hepatitis C virus (HCV) replicon and biopsy specimens of posttransplantation liver from HCV-infected patients. J Virol (2005) 1.29
The genome and proteome of coliphage T1. Virology (2004) 1.27
Mass spectrometric analyses of purified rhesus monkey rhadinovirus reveal 33 virion-associated proteins. J Virol (2006) 1.26
Crystal structure of nonstructural protein 10 from the severe acute respiratory syndrome coronavirus reveals a novel fold with two zinc-binding motifs. J Virol (2006) 1.24
Proteomics of herpes simplex virus infected cell protein 27: association with translation initiation factors. Virology (2004) 1.24
The human thioesterase II protein binds to a site on HIV-1 Nef critical for CD4 down-regulation. J Biol Chem (2000) 1.16
Targeting of host-cell ubiquitin pathways by viruses. Essays Biochem (2005) 1.14
Human cytomegalovirus tegument proteins ppUL82 (pp71) and ppUL35 interact and cooperatively activate the major immediate-early enhancer. J Virol (2004) 1.11
Deubiquitination in virus infection. Virology (2007) 1.10
Proteomic analysis of the major envelope and nucleocapsid proteins of white spot syndrome virus. J Virol (2006) 1.10
A complex of seven vaccinia virus proteins conserved in all chordopoxviruses is required for the association of membranes and viroplasm to form immature virions. Virology (2004) 1.08
Proteomic analysis of human immunodeficiency virus using liquid chromatography/tandem mass spectrometry effectively distinguishes specific incorporated host proteins. J Proteome Res (2006) 1.08
The solution structure of bacteriophage lambda protein W, a small morphogenetic protein possessing a novel fold. J Mol Biol (2001) 1.07
Thermus thermophilus bacteriophage phiYS40 genome and proteomic characterization of virions. J Mol Biol (2006) 1.06
Crystal structure of bacteriophage lambda cII and its DNA complex. Mol Cell (2005) 1.04
Structural genomics of the severe acute respiratory syndrome coronavirus: nuclear magnetic resonance structure of the protein nsP7. J Virol (2005) 1.04
Structure of the Epstein-Barr virus oncogene BARF1. J Mol Biol (2006) 1.03
The solution structure of the bacteriophage lambda head-tail joining protein, gpFII. J Mol Biol (2002) 1.02
The crystal structure of the Epstein-Barr virus protease shows rearrangement of the processed C terminus. J Mol Biol (2002) 1.00
Towards a protein interaction map of potyviruses: protein interaction matrixes of two potyviruses based on the yeast two-hybrid system. J Gen Virol (2001) 0.99
Quantitative analysis of severe acute respiratory syndrome (SARS)-associated coronavirus-infected cells using proteomic approaches: implications for cellular responses to virus infection. Mol Cell Proteomics (2005) 0.99
The crystal structure of ORF-9b, a lipid binding protein from the SARS coronavirus. Structure (2006) 0.98
Analysis of the adenovirus type 5 proteome by liquid chromatography and tandem mass spectrometry methods. J Proteome Res (2003) 0.96
Identification of cellular proteins modified in response to African swine fever virus infection by proteomics. Proteomics (2004) 0.95
Characterization of the major capsid proteins of myxoma virus particles using MALDI-TOF mass spectrometry. J Virol Methods (2005) 0.94
Molecular recognition of p53 and MDM2 by USP7/HAUSP. Nat Struct Mol Biol (2006) 1.97
Structure of the p53 binding domain of HAUSP/USP7 bound to Epstein-Barr nuclear antigen 1 implications for EBV-mediated immortalization. Mol Cell (2005) 1.92
Protein profiling with Epstein-Barr nuclear antigen-1 reveals an interaction with the herpesvirus-associated ubiquitin-specific protease HAUSP/USP7. J Biol Chem (2003) 1.78
Separation of the DNA replication, segregation, and transcriptional activation functions of Epstein-Barr nuclear antigen 1. J Virol (2002) 1.58
Protein interaction domains of the ubiquitin-specific protease, USP7/HAUSP. J Biol Chem (2003) 1.47
The EBNA1 protein of Epstein-Barr virus functionally interacts with Brd4. J Virol (2008) 1.35
Epstein-Barr nuclear antigen 1 contributes to nasopharyngeal carcinoma through disruption of PML nuclear bodies. PLoS Pathog (2008) 1.31
Genome-wide screen of three herpesviruses for protein subcellular localization and alteration of PML nuclear bodies. PLoS Pathog (2008) 1.20
EBP2 plays a key role in Epstein-Barr virus mitotic segregation and is regulated by aurora family kinases. Mol Cell Biol (2005) 1.19
The role of BiP in endoplasmic reticulum-associated degradation of major histocompatibility complex class I heavy chain induced by cytomegalovirus proteins. J Biol Chem (2006) 1.17
EBNA1-mediated recruitment of a histone H2B deubiquitylating complex to the Epstein-Barr virus latent origin of DNA replication. PLoS Pathog (2009) 1.16
Regulation of the EBNA1 Epstein-Barr virus protein by serine phosphorylation and arginine methylation. J Virol (2006) 1.16
EBNA1 partitions Epstein-Barr virus plasmids in yeast cells by attaching to human EBNA1-binding protein 2 on mitotic chromosomes. J Virol (2003) 1.11
Epstein-Barr virus nuclear antigen 1 Hijacks the host kinase CK2 to disrupt PML nuclear bodies. J Virol (2010) 1.08
Functional characterization of EBV-encoded nuclear antigen 1-specific CD4+ helper and regulatory T cells elicited by in vitro peptide stimulation. Cancer Res (2005) 1.06
MCM-BP regulates unloading of the MCM2-7 helicase in late S phase. Genes Dev (2010) 1.04
Functions of the Epstein-Barr virus EBNA1 protein in viral reactivation and lytic infection. J Virol (2012) 1.03
Identification and characterization of a novel component of the human minichromosome maintenance complex. Mol Cell Biol (2007) 1.02
Proteomic profiling of the human cytomegalovirus UL35 gene products reveals a role for UL35 in the DNA repair response. J Virol (2011) 1.01
The herpesvirus associated ubiquitin specific protease, USP7, is a negative regulator of PML proteins and PML nuclear bodies. PLoS One (2011) 1.00
Proteomic profiling of EBNA1-host protein interactions in latent and lytic Epstein-Barr virus infections. J Virol (2012) 0.96
Nucleosome assembly proteins bind to Epstein-Barr virus nuclear antigen 1 and affect its functions in DNA replication and transcriptional activation. J Virol (2009) 0.95
Nucleolar targeting of the fbw7 ubiquitin ligase by a pseudosubstrate and glycogen synthase kinase 3. Mol Cell Biol (2011) 0.94
Mitotic chromosome interactions of Epstein-Barr nuclear antigen 1 (EBNA1) and human EBNA1-binding protein 2 (EBP2). J Cell Sci (2009) 0.94
Contributions of the Epstein-Barr virus EBNA1 protein to gastric carcinoma. J Virol (2011) 0.92
Further insight into substrate recognition by USP7: structural and biochemical analysis of the HdmX and Hdm2 interactions with USP7. J Mol Biol (2010) 0.90
Stable complex formation between HIV Rev and the nucleosome assembly protein, NAP1, affects Rev function. Virology (2009) 0.89
EBNA1 efficiently assembles on chromatin containing the Epstein-Barr virus latent origin of replication. Virology (2003) 0.89
USP7/HAUSP promotes the sequence-specific DNA binding activity of p53. PLoS One (2010) 0.87
Nuclear body formation and PML body remodeling by the human cytomegalovirus protein UL35. Virology (2011) 0.86
The MCM-associated protein MCM-BP is important for human nuclear morphology. J Cell Sci (2012) 0.86
A role for USP7 in DNA replication. Mol Cell Biol (2013) 0.86
Ubiquitin-specific protease 7 is a regulator of ubiquitin-conjugating enzyme UbE2E1. J Biol Chem (2013) 0.85
Epstein-Barr virus nuclear antigen 1 replication and segregation functions in nasopharyngeal carcinoma cell lines. J Virol (2011) 0.85
Kinetically driven refolding of the hyperstable EBNA1 origin DNA-binding dimeric beta-barrel domain into amyloid-like spherical oligomers. Proteins (2008) 0.82
Interactions of the human MCM-BP protein with MCM complex components and Dbf4. PLoS One (2012) 0.81
Identification of herpesvirus proteins that contribute to G1/S arrest. J Virol (2014) 0.81
Mechanism of DNA recognition at a viral replication origin. J Biol Chem (2006) 0.80
Nucleophosmin contributes to the transcriptional activation function of the Epstein-Barr virus EBNA1 protein. J Virol (2013) 0.80
Expression profiling of herpesvirus and vaccinia virus proteins using a high-throughput baculovirus screening system. J Proteome Res (2005) 0.80
Identification of a novel protein interaction motif in the regulatory subunit of casein kinase 2. Mol Cell Biol (2013) 0.79
East-West Symposium on nasopharyngeal cancer. Int J Radiat Oncol Biol Phys (2006) 0.79
Methods for measuring the replication and segregation of Epstein-Barr virus-based plasmids. Methods Mol Biol (2005) 0.77
A role for the nucleosome assembly proteins TAF-Iβ and NAP1 in the activation of BZLF1 expression and Epstein-Barr virus reactivation. PLoS One (2013) 0.76